Belfast tech firm secures £225,000 research grant for anxiety and PTSD treatments
Neurovalens develops medical devices that deliver electrical stimulation to deep parts of the brain and nervous system
Neurovalens, a health tech start-up based in Belfast and San Diego, has secured £225,000 (€265,000) in additional funding for the development of treatments for anxiety, insomnia and PTSD using non-invasive neurostimulation.
The company’s medical devices deliver electrical stimulation to deep parts of the brain and nervous system in a bid to treat various neurological ailments without the need for implanted electrodes.
The new research and development grant was provided by Invest Northern Ireland....
Subscribe from just €1 for the first month!
With any subscription you will have access to
Unlimited multi-device access to our iPad, iPhone and Android Apps
Unlimited access to our eReader library
Exclusive daily insight and opinion seven days a week
Create alerts to never miss a subject that matters to you
Get access to exclusive offers for subscribers on gifts and experiences
Get content from Business Post, Business Post Magazines, Connected, Tatler and Food & Wine
Jazz Pharmaceuticals wins approval for HSE reimbursement of cannabis-derived drug
The company acquired GW Pharma, the UK biopharma and producer of cannabis-derived Epidiolex, earlier this year
Inside story: How Chinese biopharma firm WuXi will target European market from its €1 billion Dundalk campus
In what marks a first major foreign direct investment by a Chinese multinational in this country, WuXi has built one of the largest biopharma campuses in the world where it plans to produce 50 million vaccine doses a year – the Business Post
‘I always had entrepreneurial ambitions and this was first-hand evidence of an unmet need’
Neuromod’s chief executive Dr Ross O’Neill says his company’s Lenire device, which aids tinnitus sufferers, can establish a sizeable market — particularly in the US among military veterans
PM Group reports 30% profits increase and announces 200 new jobs in Ireland
The project delivery firm said that pharmaceutical projects accounted for almost two-thirds of its overall revenue for 2020, which rose to almost €400 million